Denali Therapeutics Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| BLACKROCK FUNDING, INC. /DE | 02/07/2025 | 13.92 M | $283.69 M | 0.96% | 8.21% |
| BAILLIE GIFFORD & CO | 01/31/2025 | 12.31 M | $250.96 M | -7.73% | 7.27% |
| VANGUARD GROUP INC | 02/11/2025 | 12.02 M | $244.99 M | 7.55% | 7.09% |
| WELLINGTON MANAGEMENT GROUP LLP | 02/12/2025 | 9.85 M | $200.70 M | -8.20% | 5.81% |
| FMR LLC | 02/13/2025 | 8.02 M | $163.44 M | 2.41% | 4.73% |
| CAPITAL RESEARCH GLOBAL INVESTORS | 02/13/2025 | 5.48 M | $111.63 M | -30.75% | 3.23% |
| TEMASEK HOLDINGS (PRIVATE) LTD | 02/14/2025 | 5.36 M | $109.15 M | 0.00% | 3.16% |
| STATE STREET CORP | 02/14/2025 | 4.54 M | $92.63 M | 6.89% | 2.68% |
| CRESTLINE MANAGEMENT, LP | 02/14/2025 | 4.31 M | $87.85 M | -3.36% | 2.54% |
| BAKER BROS. ADVISORS LP | 02/14/2025 | 3.73 M | $76.05 M | 0.00% | 2.20% |
| UBS ASSET MANAGEMENT AMERICAS INC | 02/14/2025 | 3.58 M | $73.02 M | -4.44% | 2.11% |
| ALLIANCEBERNSTEIN L.P. | 02/12/2025 | 3.32 M | $67.57 M | 8.81% | 1.96% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 02/14/2025 | 3.06 M | $62.34 M | 6.58% | 1.81% |
| GEODE CAPITAL MANAGEMENT, LLC | 02/12/2025 | 2.94 M | $59.84 M | -0.68% | 1.73% |
| CAMBER CAPITAL MANAGEMENT LP | 02/14/2025 | 2.25 M | $45.86 M | 12.50% | 1.33% |
| DIMENSIONAL FUND ADVISORS LP | 02/13/2025 | 1.86 M | $37.81 M | 18.96% | 1.09% |
| MARSHALL WACE, LLP | 02/13/2025 | 1.79 M | $36.45 M | -9.07% | 1.06% |
| BANK OF NEW YORK MELLON CORP | 02/04/2025 | 1.24 M | $25.33 M | -6.57% | 0.73% |
| PRINCIPAL FINANCIAL GROUP INC | 01/31/2025 | 1.13 M | $23.05 M | -8.68% | 0.67% |
| NORGES BANK | 02/12/2025 | 1.07 M | $21.72 M | 100.00% | 0.63% |
| GOLDMAN SACHS GROUP INC | 02/11/2025 | 1.06 M | $21.55 M | -22.69% | 0.62% |
| ARTISAN PARTNERS LIMITED PARTNERSHIP | 02/12/2025 | 1.05 M | $21.49 M | -3.35% | 0.62% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 02/06/2025 | 1.03 M | $20.96 M | 1.25% | 0.61% |
| CASDIN CAPITAL, LLC | 02/14/2025 | 990,000 | $20.18 M | 0.00% | 0.58% |
| UBS GROUP AG | 02/14/2025 | 852,861 | $17.38 M | 503.14% | 0.50% |
| SIREN, L.L.C. | 02/14/2025 | 834,028 | $17.00 M | 0.00% | 0.49% |
| CANDRIAM S.C.A. | 02/07/2025 | 832,977 | $16.98 M | -11.59% | 0.49% |
| FISHER ASSET MANAGEMENT, LLC | 02/05/2025 | 792,499 | $16.15 M | 44.79% | 0.47% |
| YIHENG CAPITAL MANAGEMENT, L.P. | 02/11/2025 | 700,098 | $14.27 M | 16.66% | 0.41% |
| CERCANO MANAGEMENT LLC | 02/14/2025 | 625,000 | $12.74 M | 0.00% | 0.37% |
| STEMPOINT CAPITAL LP | 02/14/2025 | 584,328 | $11.91 M | 107.17% | 0.34% |
| POLAR ASSET MANAGEMENT PARTNERS INC. | 02/25/2025 | 551,092 | $11.23 M | 1,240.86% | 0.33% |
| POINT72 ASSET MANAGEMENT, L.P. | 02/14/2025 | 548,739 | $11.18 M | 64.52% | 0.32% |
| AMERICAN CENTURY COMPANIES INC | 02/11/2025 | 480,529 | $9.79 M | 6.46% | 0.28% |
| BALYASNY ASSET MANAGEMENT L.P. | 02/14/2025 | 416,074 | $8.48 M | 822.40% | 0.25% |
| CLARIUS GROUP, LLC | 01/16/2025 | 409,995 | $8.36 M | 0.00% | 0.24% |
| MILLENNIUM MANAGEMENT LLC | 02/14/2025 | 404,224 | $8.24 M | 571.83% | 0.24% |
| ABRDN PLC | 01/24/2025 | 402,282 | $8.20 M | 10.61% | 0.24% |
| NUVEEN ASSET MANAGEMENT, LLC | 02/14/2025 | 355,057 | $7.24 M | -50.36% | 0.21% |
| ENSIGN PEAK ADVISORS, INC | 02/14/2025 | 346,304 | $7.06 M | 0.00% | 0.20% |
| PIER CAPITAL, LLC | 02/11/2025 | 332,319 | $6.77 M | 97.71% | 0.20% |
| QUBE RESEARCH & TECHNOLOGIES LTD | 02/14/2025 | 311,507 | $6.35 M | 100.00% | 0.18% |
| AXA S.A. | 02/14/2025 | 293,755 | $5.99 M | -14.82% | 0.17% |
| SEGALL BRYANT & HAMILL, LLC | 02/11/2025 | 289,075 | $5.89 M | 100.00% | 0.17% |
| BARCLAYS PLC | 02/13/2025 | 278,067 | $5.67 M | 8.67% | 0.16% |
| DEUTSCHE BANK AG\ | 02/14/2025 | 277,853 | $5.66 M | 15.80% | 0.16% |
| TD ASSET MANAGEMENT INC | 02/11/2025 | 265,752 | $5.42 M | 8.67% | 0.16% |
| TWINBEECH CAPITAL LP | 02/14/2025 | 254,586 | $5.19 M | 100.00% | 0.15% |
| SWISS NATIONAL BANK | 02/10/2025 | 253,500 | $5.17 M | 1.12% | 0.15% |
| SCHRODER INVESTMENT MANAGEMENT GROUP | 02/12/2025 | 247,800 | $5.02 M | 94.65% | 0.15% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Denali Therapeutics Inc. institutional Ownership - FAQ's
During the previous two years, 283 institutional investors and hedge funds held shares of Denali Therapeutics Inc.. The most heavily invested institutionals were:
BlackRock Funding, Inc. /DE: 13.92 M
BAILLIE GIFFORD & CO: 12.31 M
VANGUARD GROUP INC: 12.02 M
WELLINGTON MANAGEMENT GROUP LLP: 9.85 M
FMR LLC: 8.02 M
Capital Research Global Investors: 5.48 M
75.50% of Denali Therapeutics Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 146.07 M shares in the last 24 months. This purchase volume represents approximately $2.90 B in transactions.